Hyper-IgM syndrome: genes and variants

Explore variant evidence for Hyper-IgM syndrome across 4 analyzed proteins (CD40LG, AICDA, CD40, UNG). Linked ClinVar records include 38 pathogenic or likely pathogenic variants, 215 variants of uncertain significance and 16 with conflicting classifications.

Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.

Data updated 2026-11-05. Automated aggregation, not a clinical review date.

Download variant evidence (CSV)

Genes linked to Hyper-IgM syndrome

Where Hyper-IgM syndrome variants cluster

ClinVar pathogenic and likely pathogenic variants linked to Hyper-IgM syndrome

VariantPositionProtein partClinical label
AICDA M139V139Pathogenic / likely pathogenic (★★)
AICDA C87R87CMP/dCMP-type deaminasePathogenic / likely pathogenic (★★)
AICDA C87S87CMP/dCMP-type deaminasePathogenic / likely pathogenic (★★)
AICDA M139T139Pathogenic / likely pathogenic (★★)
CD40LG T254M254THDPathogenic / likely pathogenic (★★)
AICDA R24W24CMP/dCMP-type deaminasePathogenic / likely pathogenic (★★)
CD40LG H125Y125THDPathogenic / likely pathogenic (★★)
AICDA Y31C31CMP/dCMP-type deaminasePathogenic / likely pathogenic (★★)
AICDA R112C112CMP/dCMP-type deaminasePathogenic / likely pathogenic (★★)
CD40LG M36R36TransmembranePathogenic / likely pathogenic (★★)
AICDA V57M57CMP/dCMP-type deaminasePathogenic / likely pathogenic (★★)
AICDA M139I139Pathogenic / likely pathogenic (★)
CD40LG G257D257THDPathogenic / likely pathogenic (★)
CD40LG W140C140THDPathogenic / likely pathogenic (★)
CD40LG W140R140THDPathogenic / likely pathogenic (★)
CD40LG Y172H172THDPathogenic / likely pathogenic (★)
CD40LG Y172C172THDPathogenic / likely pathogenic (★)
CD40LG T254K254THDPathogenic / likely pathogenic (★)
CD40LG G257V257THDPathogenic / likely pathogenic (★)
AICDA L113P113CMP/dCMP-type deaminasePathogenic / likely pathogenic (★)
AICDA A111E111CMP/dCMP-type deaminasePathogenic / likely pathogenic (★)
CD40LG A123E123THDPathogenic / likely pathogenic (★)
CD40LG A141P141THDPathogenic / likely pathogenic (★)
CD40LG F229L229THDPathogenic / likely pathogenic (★)
AICDA L98R98CMP/dCMP-type deaminasePathogenic / likely pathogenic (★)
AICDA F15L15Bipartite nuclear localization signalPathogenic / likely pathogenic (★)
AICDA R24Q24CMP/dCMP-type deaminasePathogenic / likely pathogenic (★)
CD40LG G116C116ExtracellularPathogenic / likely pathogenic (★)
CD40LG G167R167THDPathogenic / likely pathogenic (★)
CD40 E144K144TNFR-Cys 3Pathogenic / likely pathogenic (★)
CD40LG S128R128THDPathogenic / likely pathogenic
CD40LG G227V227THDPathogenic / likely pathogenic
AICDA L106P106CMP/dCMP-type deaminasePathogenic / likely pathogenic
AICDA F151S151Pathogenic / likely pathogenic
CD40 C83R83TNFR-Cys 2Pathogenic / likely pathogenic
CD40LG A235P235THDPathogenic / likely pathogenic
UNG F251S251Pathogenic / likely pathogenic
CD40LG E129G129THDPathogenic / likely pathogenic

Uncertain variants prioritized for review in Hyper-IgM syndrome

VariantPositionProtein partClinical labelEvidence
AICDA C87G87CMP/dCMP-type deaminaseConflicting reports (★)+7: 2 other pathogenic changes within 3 positions; C87R at the same position is pathogenic; not seen in the gnomAD population database; REVEL 0.981
CD40LG F229S229THDConflicting reports (★)+6: 2 other pathogenic changes within 3 positions; F229L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.92
CD40LG Y172D172THDUncertain (★)+6: 2 other pathogenic changes within 3 positions; Y172H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.92
CD40LG A123V123THDUncertain (★★)+6: 2 other pathogenic changes within 3 positions; A123E at the same position is pathogenic; seen in 8.9e-06 of gnomAD DNA copies; REVEL 0.704

Which prediction tools work for Hyper-IgM syndrome

Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.

Diseases related to Hyper-IgM syndrome

Frequently asked questions

Which genes have records linked to Hyper-IgM syndrome?

This view contains 4 analyzed proteins: CD40LG, AICDA, CD40, UNG. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.

What do the clinical classifications mean?

Linked records include 38 pathogenic or likely pathogenic variants, 215 variants of uncertain significance and 16 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.

Does the evidence score change a VUS classification?

No. 4 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.

Can I download the variant evidence?

Download the CSV for all 344 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center